Can thalidomide be effective to treat plasma cell leptomeningeal infiltration? [2]

European Journal of Haematology

Volumn 70, Issue 3, 2003, Pages 198-199

  Vicari, Perla ^a   Ribas, Christian ^a   Sampaio, Manuella ^a   Arantes, Adriano M ^a   Yamamoto, Mihoko ^a   Reis Filho, João B ^a   Segreto, Roberto A ^a   Bordin, José Orlando ^a   Colleoni, Gisele W B ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hematologia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; PREDNISONE; THALIDOMIDE; VINCRISTINE;

ADULT; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; FEMALE; HUMAN; LETTER; MENINGEAL MYELOMATOSIS; MULTIPLE MYELOMA; MYELOMA; NEUROLOGIC DISEASE; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

FEMALE; HUMANS; MENINGEAL NEOPLASMS; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM INVASIVENESS; PLASMA CELLS; THALIDOMIDE;

EID: 0037799310     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00022.x     Document Type: Letter

References (6)

1. MAGHFOOR I, PERRY MC. Malignancy: meningeal myeloma: a case report and review of literature. Hematology 2000;5:47-52.
2. PATRIARCA F, ZAJA F, SILVESTRI F, SPEROTTO A, SCALISE A, GIGLI G, FANIN R. Meningeal and cerebral involve- ment in multiple myeloma patients. Ann Hematol 2001;80: 758-762.
3. RODDIE P, COLLIE D. Myelomatous involvement of the dura mater: a rare complication of multiple myeloma. J Clin Pathol 2000;53:398-399.
4. BARLOGIE B, SPENCER T, TRICOT G., et al. Long term follow-up of 169 patients receiving a phase II trial of single agent thalidomide for advanced and refractory multiple myeloma. Blood 2000; 96:514a (suppl 1, abstr).
5. ABDULRAUF SL, EDVARDSEN K, HO KL, YANG XY, ROCK JP, ROSENBLOM ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998;88:513-520.
6. SINGUAL, S, MEHTA J, DESIKAN R, et al. Antitumor activiy of thalidomide in refractory multiple myeloma. N Engl Med 1999;341:1565-1571.